Drug comparisons
Linagliptin vs Troglitazone
Compare Linagliptin vs Troglitazone for type 2 diabetes. Linagliptin (DPP-4) remains available; Troglitazone withdrawn for liver failure. Mechanisms, risks, availability.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes comparing a current DPP-4 inhibitor to a historically used but withdrawn thiazolidinedione.
Bottom line
Linagliptin is the only currently available option, as Troglitazone was withdrawn for safety reasons.
All medication comparisons